Jane Street
XTLB

Jane Street’s XTL Biopharmaceuticals XTLB Stock Holding History

Jane Street’s Portfolio XTLB Stock Details XTLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-535
Closed -$57K – 2972
2013
Q3 		$57K Buy
+535
New +$66K ﹤0.01% 2596

Other funds holding XTLB

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street's XTLB Position: Q4 2013 in Review

Jane Street sold out of XTL Biopharmaceuticals (XTLB) in Q4 2013, closing a stake of 535 shares — an estimated $57K sold.

Jane Street first reported a position in XTLB in Q3 2013 and held it in 1 quarter. The position peaked at $57K in Q3 2013. 3 funds tracked by Wall St. Rank hold XTLB as of Q4 2013.

  • Jane Street reported no remaining XTL Biopharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Jane Street sold 535 XTL Biopharmaceuticals shares in Q4 2013, an estimated $57K.
  • Jane Street first reported a position in XTL Biopharmaceuticals in Q3 2013 and held it in 1 quarter.
  • Jane Street's XTL Biopharmaceuticals position peaked at $57K in Q3 2013.
  • 3 funds tracked by Wall St. Rank held XTL Biopharmaceuticals as of Q4 2013.

Based on Jane Street's 13F filing for Q4 2013, filed 14 Feb 2014.